Toggle navigation
Home
Search
Services
Blog
Contact
About
OBI-1 - 305 Rescue theraphy, cong &acquired, all else failed
Bergman, Garrett E.
Octagen Corporation, Blue Bell, PA, United States
Search 11 grants from Garrett Bergman
Search grants from Octagen Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A powerful web-based discovery platform for rare disease genetics
Intervention for Menstrual Mood Disorders &Early Life Abuse: Biopsych Mechanisms
Anti-inflammatory lipids in acute mucosal inflammation
Comprehensive Animal Care
NSF/DOE Partnership on Advanced Combustion Engines: Ignition and Combustion Characteristics of Transportation Fuels under Lean-Burn Conditions for Advanced Engine Concepts
Recently added grants:
Pathomechanisms of SCN3A-related neurodevelopmental disorder
Role of IL-7R in CNS autoimmunity
Neurodevelopment after postnatal Zika virus infection in infant macaques
Improved staging of lobular breast cancer with novel amino acid metabolic and tumor neovasculature receptor imaging.
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44HL064497-04
Application #
7149845
Study Section
Special Emphasis Panel (ZRG1)
Project Start
2005-08-01
Project End
2008-07-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Octagen Corporation
Department
Type
DUNS #
052982852
City
Blue Bell
State
PA
Country
United States
Zip Code
19422
Related projects
Comments
Be the first to comment on Garrett Bergman's grant